Moderna
MRNA
#1474
Rank
C$20.67 B
Marketcap
C$52.92
Share price
12.65%
Change (1 day)
4.44%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$20.67 Billion

As of January 2026 Moderna has a market cap of C$20.67 Billion. This makes Moderna the world's 1474th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026C$20.67 B23.85%
2025C$16.69 B-24.66%
2024C$22.16 B-55.94%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Moderna was reported to be:

C$18.35 Billion
by Nasdaq info icon info icon
C$18.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
C$0.78 B-96.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$373.69 B 1,707.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$1.15 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$68.06 B 229.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$377.51 B 1,725.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
C$13.20 B-36.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$711.35 B 3,340.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.13 B-80.01%๐Ÿ‡บ๐Ÿ‡ธ USA